You searched for "ESCRS"
Samsung focuses on the sight impaired and internet security flaws
1 June 2014
| David Haider
|
EYE - General
Smartphone assistive technology for the sight impaired In previous issues we’ve covered some specific smartphones that have been developed for the sight impaired. Samsung are now doing something similar, but in the form of accessories. In March 2014 they announced,...
Expensive Malware
1 February 2014
| David Haider
Cryptolocker and similar ransomware There is a new breed of computer malware that is spreading rapidly. The first major manifestation of this new type is known as Cryptolocker. At present it’s a Windows only problem (all versions), but it’s likely...
Envision Glasses – a different take on a sight impairment wearable (part 1)
1 December 2021
| David Haider
|
EYE - General
In recent issues we reviewed the OrCam MyEye Pro, a glasses mounted mobile device that can assist sight impaired users. This time we are taking a look at the Envision Glasses, a comparable device that takes a different approach (see...
Empatheyes
4 December 2023
| David Haider
For Dec/Jan 2024 we are showcasing a remarkably well-named technological solution. Empatheyes provides a unique way for people to increase their understanding of the experience of having a sight disorder. Whether for parents of children with sight disorders, corporate awareness...
The medical student syndrome
1 April 2016
| Alysha Bhatti
|
EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
It is often said that “a little learning is a dangerous thing,” but being super savvy can’t put us at the brink of harm, can it? Each year as thousands of students commence their medical degrees, they begin a journey...
Management of retinal diseases: highlights from the AAO 2019 Retina Subspecialty Day Meeting
The author highlights current debate, opinion and late breaking developments in the management of retinal diseases. The American Academy of Ophthalmology’s 2019 Retina Subspecialty Day Meeting was held on 11-12 October, 2019 in San Francisco, USA. Established and emerging innovative...Renewed momentum in ocular gene and cell therapy, broadening application to chronic disease
Gene and cell therapies offer the prospect of ground-breaking new avenues for the treatment of diseases, reflected in a renewed explosion of interest and investment in retinal gene therapy. Rod McNeil reports recent clinical trial readouts across a diverse range...Belfast briefing: Retina Day roundup from the RCOphth 2024 Annual Congress
2 August 2024
| Rod McNeil
|
EYE - General
Belfast hosted this year’s Royal College of Ophthalmologists’ (RCOphth) Annual Congress, a meeting dedicated to sharing advances, knowledge and clinical practice points in ophthalmic care. This article summarises selected talks by medical and surgical retina specialists during the Retina Subspecialty...
Update on emerging therapies for age-related macular degeneration
4 December 2023
| Rod McNeil
|
EYE - Vitreo-Retinal
The 23rd European Society of Retina Specialists (EURETINA) Congress, held in Amsterdam, the Netherlands, provided a timely update on anti-complement therapy for geographic atrophy and emerging investigational therapies for neovascular age-related macular degeneration. Anti-complement therapy for geographic atrophy Geographic atrophy...
Specialty-driven EMR for paperless clinical environment – insights for an informed choice
1 August 2016
| Rod McNeil
|
EYE - General
Deployment of specialty-driven (or specialty-specific) electronic medical record (EMR) systems across UK ophthalmology units appears to be growing rapidly at the expense of generic, multiuse digital technology packages. Experience further suggests that open source systems can play a significant role...
Farnborough International Airshow 2022 partners with Orbis UK
18 July 2022
Farnborough International Airshow (FIA) announces Orbis UK as its official charity partner for 2022.
